In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa.

Podobne zapisy

• Pharmacokinetic and pharmacodynamic activities of ciprofloxacin against strains of Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa for which MICs are similar.
  od: Hyatt, J M, i wsp.
  Wydane: (1994)
• Synergistic Activities of Moxifloxacin Combined with Piperacillin-Tazobactam or Cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii Clinical Isolates
  od: Jung, Rose, i wsp.
  Wydane: (2004)
• Ciprofloxacin in neonatal Enterobacter cloacae septicaemia.
  od: Bannon, M J, i wsp.
  Wydane: (1989)
• Pharmacodynamics of piperacillin alone and in combination with tazobactam against piperacillin-resistant and -susceptible organisms in an in vitro model of infection.
  od: Strayer, A H, i wsp.
  Wydane: (1994)
• In Vitro Pharmacodynamics of Fosfomycin against Carbapenem-Resistant Enterobacter cloacae and Klebsiella aerogenes
  od: Lim, Tze-Peng, i wsp.
  Wydane: (2020)